IBX 0.00% 8.5¢ imagion biosystems limited

Ann: Imagion Announces Positive Results from Phase 1 Study, page-25

  1. 1,395 Posts.
    lightbulb Created with Sketch. 444
    Yep, first shot on goal was a flop. Can't see clinical or commercial success for HER2.

    Prostate is a possibility. But huge competition from existing and pipeline products. TLX, CU6, RAD are in the prostate cancer imaging space. Sure, MRI easier than PET, if it works that is.

    This company will take YEARS to even start trials in prostate or others.
 
watchlist Created with Sketch. Add IBX (ASX) to my watchlist
(20min delay)
Last
8.5¢
Change
0.000(0.00%)
Mkt cap ! $2.775M
Open High Low Value Volume
8.4¢ 8.5¢ 8.3¢ $7.711K 91.77K

Buyers (Bids)

No. Vol. Price($)
1 1152 8.5¢
 

Sellers (Offers)

Price($) Vol. No.
8.7¢ 1250 1
View Market Depth
Last trade - 15.57pm 28/06/2024 (20 minute delay) ?
IBX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.